Patent details
EP2173348 Title: POTENTIATION OF CANCER CHEMOTHERAPY
Basic Information
- Publication number:
- EP2173348
- PCT Application Number:
- PCT/US/2008/067614
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP087715595
- PCT Publication Number:
- WO/2009/006043
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- POTENTIATION OF CANCER CHEMOTHERAPY
- French Title of Invention:
- POTENTIALISATION DE LA CHIMIOTHÉRAPIE DU CANCER
- German Title of Invention:
- POTENZIERUNG VON KREBS-CHEMOTHERAPIEN
- SPC Number:
Dates
- Filing date:
- 20/06/2008
- Grant date:
- 09/12/2015
- EP Publication Date:
- 09/12/2015
- PCT Publication Date:
- 08/01/2009
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 14/04/2010
- EP B1 Publication Date:
- 09/12/2015
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 20/06/2016
- Expiration date:
- 20/06/2028
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 20/06/2008
- Name:
- Eli Lilly & Company
- Address:
- Lilly Corporate Center, Indianapolis, IN 46285, United States (US)
Inventor
1
- Name:
- ABURUB Aktham
- Address:
- United States (US)
2
- Name:
- ENGLER Thomas, Albert
- Address:
- United States (US)
3
- Name:
- CHEDID Marcio
- Address:
- United States (US)
4
- Name:
- VASUDEVAN Venkatraghavan
- Address:
- United States (US)
Priority
- Priority Number:
- 947512 P
- Priority Date:
- 02/07/2007
- Priority Country:
- United States (US)
Classification
- Main IPC Class:
- A61K 31/4745;
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|